Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced a new enhancement to its automated quality control (QC) solution, AiosynQC. The latest...

Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, is thrilled to announce the integration of its NephroPath AI tools into HistoWiz’s PathologyMap™ platform....

Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced its external digital slide quality assessments to support laboratories in achieving good-quality histology slides—essential for...

NIJMEGEN, the Netherlands – Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for kidney disease and breast cancer, has integrated its glomerular quantification algorithm with Sectra’s diagnostic...

From Aiosyn via Pathology News: What is chronic kidney disease (CKD)? Chronic kidney disease (CKD) is a progressive condition where the kidneys gradually lose function [1]. It is characterized by a high morbidity and mortality rate, and it is...

NETHERLANDS and NEW YORK CITY – Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for cancer and kidney disease, and HistoWiz, a leading provider of histology and slide archiving services, today announced...